truebeam renaiss continu
put sizabl beat faster convers along
strength software/servic sustain teen growth truebeam
continu drive substanti order flow part driven new account
open halcyon us tariff bake think tune
offici wildcard ahead mitig effort
take hold tweak adjust pt ahead clariti
discrep product instal growth softwar continu
get push back discrep product revenu growth cc ytd instal
base growth cc ytd one clear driver softwar fall product revenu
line see page recent grew cc growth driven uptak
rapidplan instal base increas licens order reach all-tim high
delta also driven faster instal cycl select product truebeam
across select geographi high base retent rate competit situat
oncolog order truebeam renaiss halcyon pull-through oncolog
gross order well ahead expect cc cc strength truebeam
increas contribut halcyon truebeam post close order incl
order win nh lead demand speed versatil remain import
driver halcyon order increas last major come new
account turn purchas increment truebeam serv halo effect
portfolio
tariff bake wildcard disclos
impli ep guidanc incl impact tariff went effect
earli juli link us tariff product list preview note link calcul
gm headwind ep impact rough math appear match well
revis guidanc point toward potenti headwind next year depend
timing/ext mitig effort
tweak pt portfolio work tariff present risk
go prior reflect report top-lin growth
organ growth strong ytd truebeam order teen softwar growth
see oncolog potenti upsid importantli ep forecast includ
impact us tariff ahead clariti mitig effort repres
potenti headwind/sourc downsid depend time
price price aftermarket trade close
pleas see analyst certif import disclosur inform inform regard statu non-u analyst page report
invest thesi predic on-going oncolog
book cycl us market captur new
strong imrt/srs/sbrt reimburs continu drive
adopt usag
innov proton therapi set gain traction
outcom us tariff mitig effort
high-singl digit oncolog order growth support us
replac emerg market growth halcyon
oncolog gm remain stabl rang
softwar halycon upsid
proton therapi stabil achiev profit exit
mid-singl digit oncolog order growth support us
oncolog gm exce faster softwar growth
greater expect contribut halcyon
follow-on accret softwar
proton order sale delay
reimburs rate imrt cut demand fall
oncolog margin deterior
halcyon growth materi
market share loss competitor new therapi
market share loss competitor new therapi
potenti headwind us tariff
mr-uniti receiv clearanc ahead schedul
captur market share
page
pleas see import disclosur inform page report
